Literature DB >> 15224117

Cell culture and animal models of viral hepatitis. Part I: hepatitis B.

Chandan Guha1, Sankar Mohan, Namita Roy-Chowdhury, Jayanta Roy-Chowdhury.   

Abstract

Despite the existence of a preventative vaccine, HBV represents a substantial threat to public health, suggesting the need for research to develop new treatments to combat the disease. The authors review the available in vitro and in vivo models, including recently developed transgenic and chimeric mouse models.

Entities:  

Mesh：

Year:  2004        PMID： 15224117     DOI： 10.1038/laban0704-37

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN： 0093-7355            Impact factor:   12.625


  8 in total

Review 1.  High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay.

Authors:  Sandeep Amberkar; Narsis A Kiani; Ralf Bartenschlager; Gualtiero Alvisi; Lars Kaderali
Journal:  World J Virol       Date:  2013-05-12

2.  Hepatitis B virus infection and replication in primarily cultured human fetal hepatocytes.

Authors:  Min Lin; Qun Chen; Li-Ye Yang; Wen-Yu Li; Xi-Biao Cao; Jiao-Ren Wu; You-Peng Peng; Mo-Rui Chen
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

3.  Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients.

Authors:  Yin-Ping Lu; Tao Guo; Bao-Ju Wang; Ji-Hua Dong; Jian-Fang Zhu; Zhao Liu; Meng-Ji Lu; Dong-Liang Yang
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies.

Authors:  Thomas Hiller; Johanna Berg; Laura Elomaa; Viola Röhrs; Imran Ullah; Katrin Schaar; Ann-Christin Dietrich; Munir A Al-Zeer; Andreas Kurtz; Andreas C Hocke; Stefan Hippenstiel; Henry Fechner; Marie Weinhart; Jens Kurreck
Journal:  Int J Mol Sci       Date:  2018-10-12       Impact factor: 5.923

5.  The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice.

Authors:  Jia-Ming Chang; Kai-Ling Huang; Thomas Ta-Tung Yuan; Yiu-Kay Lai; Le-Mei Hung
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-07       Impact factor: 2.629

6.  Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans.

Authors:  Qi Wang; Paul Schwarzenberger; Fang Yang; Jingjing Zhang; Jianjia Su; Chun Yang; Ji Cao; Chao Ou; Liang Liang; Junlin Shi; Fang Yang; Duoping Wang; Jia Wang; Xiaojuan Wang; Ping Ruan; Yuan Li
Journal:  Virol J       Date:  2012-08-23       Impact factor: 4.099

7.  CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation.

Authors:  Xiaojing Wang; Weiming Yan; Yulei Lu; Tao Chen; Ying Sun; Xiaomin Qin; Jiangguo Zhang; Meifang Han; Wei Guo; Hongwu Wang; Di Wu; Dong Xi; Xiaoping Luo; Qin Ning
Journal:  Cell Immunol       Date:  2012-12-01       Impact factor: 4.868

Review 8.  In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations.

Authors:  Constance N Wose Kinge; Nimisha H Bhoola; Anna Kramvis
Journal:  Viruses       Date:  2020-03-23       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.